Danaher (NYSE:DHR) Rating Lowered to Hold at StockNews.com

Danaher (NYSE:DHR) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Tuesday.

A number of other research analysts have also commented on the company. Barclays increased their price objective on Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a report on Wednesday, April 24th. Robert W. Baird lifted their target price on Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, April 24th. Jefferies Financial Group began coverage on Danaher in a research note on Monday, June 3rd. They set a “buy” rating and a $295.00 price objective for the company. TD Cowen boosted their price target on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a report on Wednesday, April 24th. Finally, Bank of America boosted their price target on Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 24th. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $269.29.

Danaher Trading Down 0.1 %

NYSE:DHR opened at $253.77 on Tuesday. Danaher has a 1 year low of $182.09 and a 1 year high of $269.11. The stock has a market cap of $187.96 billion, a price-to-earnings ratio of 43.01, a PEG ratio of 3.89 and a beta of 0.85. The business has a fifty day moving average of $255.07 and a 200-day moving average of $246.14. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating the consensus estimate of $1.72 by $0.20. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. Danaher’s revenue was down 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $2.36 earnings per share. Equities analysts predict that Danaher will post 7.63 earnings per share for the current year.

Insider Activity

In related news, SVP Brian W. Ellis sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total value of $1,000,040.00. Following the transaction, the senior vice president now owns 29,830 shares of the company’s stock, valued at approximately $7,457,798.30. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, CEO Rainer Blair sold 47,175 shares of Danaher stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total value of $11,756,953.50. Following the completion of the transaction, the chief executive officer now directly owns 115,995 shares in the company, valued at approximately $28,908,273.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Brian W. Ellis sold 4,000 shares of the company’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the completion of the transaction, the senior vice president now directly owns 29,830 shares in the company, valued at approximately $7,457,798.30. The disclosure for this sale can be found here. Insiders sold a total of 148,783 shares of company stock worth $37,536,717 in the last three months. Company insiders own 10.90% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. ST Germain D J Co. Inc. boosted its holdings in shares of Danaher by 1.4% during the first quarter. ST Germain D J Co. Inc. now owns 2,880 shares of the conglomerate’s stock worth $719,000 after purchasing an additional 41 shares during the period. Godsey & Gibb Inc. boosted its stake in shares of Danaher by 3.0% during the 1st quarter. Godsey & Gibb Inc. now owns 1,442 shares of the conglomerate’s stock worth $360,000 after acquiring an additional 42 shares during the last quarter. Nicholas Hoffman & Company LLC. lifted its stake in shares of Danaher by 2.3% during the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock valued at $439,000 after buying an additional 43 shares in the last quarter. Berger Financial Group Inc lifted its stake in shares of Danaher by 1.7% during the 4th quarter. Berger Financial Group Inc now owns 2,517 shares of the conglomerate’s stock valued at $582,000 after buying an additional 43 shares in the last quarter. Finally, Los Angeles Capital Management LLC increased its holdings in Danaher by 1.3% in the 4th quarter. Los Angeles Capital Management LLC now owns 3,470 shares of the conglomerate’s stock valued at $803,000 after acquiring an additional 43 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.